Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 313

1.

Clostridium difficile in Asia: Opportunities for One Health Management.

Collins DA, Riley TV.

Trop Med Infect Dis. 2018 Dec 28;4(1). pii: E7. doi: 10.3390/tropicalmed4010007. Review.

2.

A series of three cases of severe Clostridium difficile infection in Australia associated with a binary toxin producing clade 2 ribotype 251 strain.

Wehrhahn MC, Keighley C, Kurtovic J, Knight DR, Hong S, Hutton ML, Lyras D, Wang Q, Leong R, Borody T, Edye M, Riley TV.

Anaerobe. 2018 Nov 27;55:117-123. doi: 10.1016/j.anaerobe.2018.11.009. [Epub ahead of print]

PMID:
30500477
3.

Natural products show diverse mechanisms of action against Clostridium difficile.

Roshan N, Riley TV, Knight DR, Steer JH, Hammer KA.

J Appl Microbiol. 2019 Feb;126(2):468-479. doi: 10.1111/jam.14152. Epub 2018 Dec 26.

PMID:
30412324
4.

Effect of natural products on the production and activity of Clostridium difficile toxins in vitro.

Roshan N, Riley TV, Knight DR, Hammer KA.

Sci Rep. 2018 Oct 24;8(1):15735. doi: 10.1038/s41598-018-33954-2.

5.

Genomic Analysis of Multiresistant Staphylococcus capitis Associated with Neonatal Sepsis.

Carter GP, Ussher JE, Da Silva AG, Baines SL, Heffernan H, Riley TV, Broadbent R, van der Linden A, Lee J, Monk IR, Stinear TP, Howden BP, Williamson DA.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e00898-18. doi: 10.1128/AAC.00898-18. Print 2018 Nov.

6.

Antimicrobial resistance in large clostridial toxin-negative, binary toxin-positive Clostridium difficile ribotypes.

Androga GO, Knight DR, Lim SC, Foster NF, Riley TV.

Anaerobe. 2018 Dec;54:55-60. doi: 10.1016/j.anaerobe.2018.07.007. Epub 2018 Jul 25.

PMID:
30053486
7.

Diverse bacterial species contribute to antibiotic-associated diarrhoea and gastrointestinal damage.

Larcombe S, Hutton ML, Riley TV, Abud HE, Lyras D.

J Infect. 2018 Nov;77(5):417-426. doi: 10.1016/j.jinf.2018.06.006. Epub 2018 Jun 30.

PMID:
29964142
8.

Antimicrobial susceptibility of Clostridium difficile isolated from food and environmental sources in Western Australia.

Lim SC, Androga GO, Knight DR, Moono P, Foster NF, Riley TV.

Int J Antimicrob Agents. 2018 Sep;52(3):411-415. doi: 10.1016/j.ijantimicag.2018.05.013. Epub 2018 May 23.

PMID:
29802886
9.

Spectrum of antibacterial activity and mode of action of a novel tris-stilbene bacteriostatic compound.

Man NYT, Knight DR, Stewart SG, McKinley AJ, Riley TV, Hammer KA.

Sci Rep. 2018 May 2;8(1):6912. doi: 10.1038/s41598-018-25080-w.

10.

Effects of natural products on several stages of the spore cycle of Clostridium difficile in vitro.

Roshan N, Riley TV, Hammer KA.

J Appl Microbiol. 2018 Sep;125(3):710-723. doi: 10.1111/jam.13889. Epub 2018 Jun 26.

PMID:
29675852
11.

Clostridium difficile Guidelines.

Collins DA, Riley TV.

Clin Infect Dis. 2018 Oct 30;67(10):1639. doi: 10.1093/cid/ciy249. No abstract available.

PMID:
29590322
12.

High Prevalence of Toxigenic and Nontoxigenic Clostridium difficile Strains in Malaysia.

Riley TV, Collins DA, Karunakaran R, Kahar MA, Adnan A, Hassan SA, Zainul NH, Rustam FRM, Wahab ZA, Ramli R, Lee YY, Hassan H.

J Clin Microbiol. 2018 May 25;56(6). pii: e00170-18. doi: 10.1128/JCM.00170-18. Print 2018 Jun.

13.

Changes in knowledge and attitudes of hospital environmental services staff: The Researching Effective Approaches to Cleaning in Hospitals (REACH) study.

Mitchell BG, White N, Farrington A, Allen M, Page K, Gardner A, Halton K, Riley TV, Gericke CA, Paterson DL, Graves N, Hall L.

Am J Infect Control. 2018 Sep;46(9):980-985. doi: 10.1016/j.ajic.2018.02.003. Epub 2018 Mar 14.

14.

Evaluation of the Cepheid® Xpert®C. difficile binary toxin (BT) diagnostic assay.

McGovern AM, Androga GO, Moono P, Collins DA, Foster NF, Chang BJ, Riley TV.

Anaerobe. 2018 Jun;51:12-16. doi: 10.1016/j.anaerobe.2018.03.004. Epub 2018 Mar 11.

PMID:
29534914
15.

1,2,4-Oxadiazole antimicrobials act synergistically with daptomycin and display rapid kill kinetics against MDR Enterococcus faecium.

Carter GP, Harjani JR, Li L, Pitcher NP, Nong Y, Riley TV, Williamson DA, Stinear TP, Baell JB, Howden BP.

J Antimicrob Chemother. 2018 Jun 1;73(6):1562-1569. doi: 10.1093/jac/dky064.

PMID:
29518208
16.

The Epidemiology of Clostridium difficile Infection in Japan: A Systematic Review.

Riley TV, Kimura T.

Infect Dis Ther. 2018 Mar;7(1):39-70. doi: 10.1007/s40121-018-0186-1. Epub 2018 Feb 13. Review.

17.

Non-conventional antimicrobial and alternative therapies for the treatment of Clostridium difficile infection.

Roshan N, Hammer KA, Riley TV.

Anaerobe. 2018 Feb;49:103-111. doi: 10.1016/j.anaerobe.2018.01.003. Epub 2018 Jan 6. Review.

PMID:
29309845
18.

Zoonotic Transfer of Clostridium difficile Harboring Antimicrobial Resistance between Farm Animals and Humans.

Knetsch CW, Kumar N, Forster SC, Connor TR, Browne HP, Harmanus C, Sanders IM, Harris SR, Turner L, Morris T, Perry M, Miyajima F, Roberts P, Pirmohamed M, Songer JG, Weese JS, Indra A, Corver J, Rupnik M, Wren BW, Riley TV, Kuijper EJ, Lawley TD.

J Clin Microbiol. 2018 Feb 22;56(3). pii: e01384-17. doi: 10.1128/JCM.01384-17. Print 2018 Mar.

19.

High prevalence of Clostridium difficile on retail root vegetables, Western Australia.

Lim SC, Foster NF, Elliott B, Riley TV.

J Appl Microbiol. 2018 Feb;124(2):585-590. doi: 10.1111/jam.13653.

PMID:
29193458
20.

Prevalence of binary toxin positive Clostridium difficile in diarrhoeal humans in the absence of epidemic ribotype 027.

McGovern AM, Androga GO, Knight DR, Watson MW, Elliott B, Foster NF, Chang BJ, Riley TV.

PLoS One. 2017 Nov 8;12(11):e0187658. doi: 10.1371/journal.pone.0187658. eCollection 2017.

21.

Clostridium difficile infection in the Lao People's Democratic Republic: first isolation and review of the literature.

Cheong E, Roberts T, Rattanavong S, Riley TV, Newton PN, Dance DAB.

BMC Infect Dis. 2017 Sep 21;17(1):635. doi: 10.1186/s12879-017-2737-6. Review.

22.

Prevalence of Clostridium difficile infection and colonization in a tertiary hospital and elderly community of North-Eastern Peninsular Malaysia.

Zainul NH, Ma ZF, Besari A, Siti Asma H, Rahman RA, Collins DA, Hamid N, Riley TV, Lee YY.

Epidemiol Infect. 2017 Oct;145(14):3012-3019. doi: 10.1017/S0950268817002011. Epub 2017 Sep 11.

PMID:
28891459
23.

Epidemiology of Clostridium difficile in infants in Oxfordshire, UK: Risk factors for colonization and carriage, and genetic overlap with regional C. difficile infection strains.

Stoesser N, Eyre DW, Quan TP, Godwin H, Pill G, Mbuvi E, Vaughan A, Griffiths D, Martin J, Fawley W, Dingle KE, Oakley S, Wanelik K, Finney JM, Kachrimanidou M, Moore CE, Gorbach S, Riley TV, Crook DW, Peto TEA, Wilcox MH, Walker AS; Modernising Medical Microbiology Informatics Group (MMMIG).

PLoS One. 2017 Aug 16;12(8):e0182307. doi: 10.1371/journal.pone.0182307. eCollection 2017.

24.

Community-associated Clostridium difficile infection in emergency department patients in Western Australia.

Collins DA, Selvey LA, Celenza A, Riley TV.

Anaerobe. 2017 Dec;48:121-125. doi: 10.1016/j.anaerobe.2017.08.008. Epub 2017 Aug 12.

PMID:
28807622
25.

Aboriginal and non-Aboriginal children in Western Australia carry different serotypes of pneumococci with different antimicrobial susceptibility profiles.

Dunne EM, Carville K, Riley TV, Bowman J, Leach AJ, Cripps AW, Murphy D, Jacoby P, Lehmann D; Kalgoorlie Otitis Media Research Project Team.

Pneumonia (Nathan). 2016 Sep 5;8:15. doi: 10.1186/s41479-016-0015-9. eCollection 2016.

26.

Prevalence and molecular epidemiology of Clostridium difficile infection in Indonesia.

Collins DA, Gasem MH, Habibie TH, Arinton IG, Hendriyanto P, Hartana AP, Riley TV.

New Microbes New Infect. 2017 May 4;18:34-37. doi: 10.1016/j.nmni.2017.04.006. eCollection 2017 Jul.

27.

Antimicrobial susceptibility of Clostridium difficile isolated in Thailand.

Putsathit P, Maneerattanaporn M, Piewngam P, Knight DR, Kiratisin P, Riley TV.

Antimicrob Resist Infect Control. 2017 Jun 8;6:58. doi: 10.1186/s13756-017-0214-z. eCollection 2017.

28.

Correction for Cairns et al., "Comparative Genome Analysis and Global Phylogeny of the Toxin Variant Clostridium difficile PCR Ribotype 017 Reveals the Evolution of Two Independent Sublineages".

Cairns MD, Preston MD, Hall CL, Gerding DN, Hawkey PM, Kato H, Kim H, Kuijper EJ, Lawley TD, Pituch H, Reid S, Kullin B, Riley TV, Solomon K, Tsai PJ, Weese JS, Stabler RA, Wren BW.

J Clin Microbiol. 2017 Jun;55(6):1971. doi: 10.1128/JCM.00487-17. No abstract available.

29.

Comparison of two environmental sampling tools for the detection of Clostridium difficile spores on hard bathroom surfaces in the hospital setting.

Engelhardt NEP, Foster NF, Hong S, Riley TV, McGechie DB.

J Hosp Infect. 2017 Jul;96(3):295-296. doi: 10.1016/j.jhin.2017.03.028. Epub 2017 Mar 31. No abstract available.

PMID:
28495188
30.

Antimicrobial activity of natural products against Clostridium difficile in vitro.

Roshan N, Riley TV, Hammer KA.

J Appl Microbiol. 2017 May 10. doi: 10.1111/jam.13486. [Epub ahead of print]

PMID:
28489336
31.

Human Clostridium difficile infection caused by a livestock-associated PCR ribotype 237 strain in Western Australia.

Mc Govern AM, Foster NF, Pereira LA, Knight DR, Elliott B, Chang BJ, Riley TV.

JMM Case Rep. 2016 Aug 30;3(4):e005062. doi: 10.1099/jmmcr.0.005062. eCollection 2016 Aug.

32.

Laboratory-based surveillance of Clostridium difficile strains circulating in the Australian healthcare setting in 2012.

Collins DA, Putsathit P, Elliott B, Riley TV.

Pathology. 2017 Apr;49(3):309-313. doi: 10.1016/j.pathol.2016.10.013. Epub 2017 Feb 23.

PMID:
28237369
33.

High prevalence of toxigenic Clostridium difficile in public space lawns in Western Australia.

Moono P, Lim SC, Riley TV.

Sci Rep. 2017 Feb 1;7:41196. doi: 10.1038/srep41196.

34.
35.

Prevalence and molecular epidemiology of Clostridium difficile infection in Thailand.

Putsathit P, Maneerattanaporn M, Piewngam P, Kiratisin P, Riley TV.

New Microbes New Infect. 2016 Oct 21;15:27-32. doi: 10.1016/j.nmni.2016.10.004. eCollection 2017 Jan.

36.

Burden of Clostridium difficile infection: Associated hospitalization in a cohort of middle-aged and older adults.

Chen Y, Glass K, Liu B, Korda RJ, Riley TV, Kirk MD.

Am J Infect Control. 2017 May 1;45(5):508-511. doi: 10.1016/j.ajic.2016.12.006. Epub 2017 Jan 13.

PMID:
28089675
37.

Comparative Genome Analysis and Global Phylogeny of the Toxin Variant Clostridium difficile PCR Ribotype 017 Reveals the Evolution of Two Independent Sublineages.

Cairns MD, Preston MD, Hall CL, Gerding DN, Hawkey PM, Kato H, Kim H, Kuijper EJ, Lawley TD, Pituch H, Reid S, Kullin B, Riley TV, Solomon K, Tsai PJ, Weese JS, Stabler RA, Wren BW.

J Clin Microbiol. 2017 Mar;55(3):865-876. doi: 10.1128/JCM.01296-16. Epub 2016 Dec 28. Erratum in: J Clin Microbiol. 2017 Jun;55(6):1971.

38.

Clostridium difficile infection: Evolution, phylogeny and molecular epidemiology.

Elliott B, Androga GO, Knight DR, Riley TV.

Infect Genet Evol. 2017 Apr;49:1-11. doi: 10.1016/j.meegid.2016.12.018. Epub 2016 Dec 22. Review.

PMID:
28012982
39.

Comparison of Clostridium difficile Ribotypes Circulating in Australian Hospitals and Communities.

Furuya-Kanamori L, Riley TV, Paterson DL, Foster NF, Huber CA, Hong S, Harris-Brown T, Robson J, Clements AC.

J Clin Microbiol. 2016 Dec 28;55(1):216-225. doi: 10.1128/JCM.01779-16. Print 2017 Jan.

40.

Asymptomatic Clostridium difficile colonization in two Australian tertiary hospitals, 2012-2014: prospective, repeated cross-sectional study.

Furuya-Kanamori L, Clements ACA, Foster NF, Huber CA, Hong S, Harris-Brown T, Yakob L, Paterson DL, Riley TV.

Clin Microbiol Infect. 2017 Jan;23(1):48.e1-48.e7. doi: 10.1016/j.cmi.2016.08.030. Epub 2016 Sep 8.

41.

A population-based longitudinal study of Clostridium difficile infection-related hospitalization in mid-age and older Australians.

Chen Y, Glass K, Liu B, Riley TV, Korda R, Kirk MD.

Epidemiol Infect. 2017 Feb;145(3):575-582. doi: 10.1017/S0950268816002260. Epub 2016 Oct 26.

PMID:
27780483
42.

Clostridium difficile Infection in Production Animals and Avian Species: A Review.

Moono P, Foster NF, Hampson DJ, Knight DR, Bloomfield LE, Riley TV.

Foodborne Pathog Dis. 2016 Dec;13(12):647-655. Epub 2016 Sep 7. Review.

PMID:
27602596
43.

A Phenotypically Silent vanB2 Operon Carried on a Tn1549-Like Element in Clostridium difficile.

Knight DR, Androga GO, Ballard SA, Howden BP, Riley TV.

mSphere. 2016 Aug 10;1(4). pii: e00177-16. doi: 10.1128/mSphere.00177-16. eCollection 2016 Jul-Aug.

44.

Community-Acquired Clostridium difficile Infection, Queensland, Australia.

Furuya-Kanamori L, Yakob L, Riley TV, Paterson DL, Baker P, McKenzie SJ, Robson J, Clements AC.

Emerg Infect Dis. 2016 Sep;22(9):1659-61. doi: 10.3201/eid2209.151115. No abstract available.

45.

Epidemiology and Risk Factors for Community-Associated Clostridium difficile Infection: A Narrative Review.

Bloomfield LE, Riley TV.

Infect Dis Ther. 2016 Sep;5(3):231-51. doi: 10.1007/s40121-016-0117-y. Epub 2016 Jul 1. Review.

46.

Clostridium difficile Infections amongst Patients with Haematological Malignancies: A Data Linkage Study.

Selvey LA, Slimings C, Joske DJ, Riley TV.

PLoS One. 2016 Jun 17;11(6):e0157839. doi: 10.1371/journal.pone.0157839. eCollection 2016.

47.

Comparison of the Vidas C. difficile and Quik Chek-60 glutamate dehydrogenase assays for the detection of Clostridium difficile in faecal samples.

Carson KC, Riley TV.

Pathology. 2016 Aug;48(5):506-8. doi: 10.1016/j.pathol.2016.04.007. Epub 2016 Jun 14. No abstract available.

PMID:
27311869
48.

Clostridium difficile clade 5 in Australia: antimicrobial susceptibility profiling of PCR ribotypes of human and animal origin.

Knight DR, Riley TV.

J Antimicrob Chemother. 2016 Aug;71(8):2213-7. doi: 10.1093/jac/dkw124. Epub 2016 Apr 29.

PMID:
27130808
49.

Australasian Society of Infectious Diseases updated guidelines for the management of Clostridium difficile infection in adults and children in Australia and New Zealand.

Trubiano JA, Cheng AC, Korman TM, Roder C, Campbell A, May ML, Blyth CC, Ferguson JK, Blackmore TK, Riley TV, Athan E.

Intern Med J. 2016 Apr;46(4):479-93. doi: 10.1111/imj.13027.

PMID:
27062204
50.

Laboratory-based surveillance of Clostridium difficile circulating in Australia, September - November 2010.

Cheng AC, Collins DA, Elliott B, Ferguson JK, Paterson DL, Thean S, Riley TV.

Pathology. 2016 Apr;48(3):257-60. doi: 10.1016/j.pathol.2016.02.005. Epub 2016 Mar 2.

PMID:
27020502

Supplemental Content

Loading ...
Support Center